bf/NASDAQ:CSBR_icon.jpeg

NASDAQ:CSBR

Champions Oncology

  • Stock

6.38

−10.77%

−0.15

USD last updated 13/08 01:59:42

Last Close

6.53

12/08 20:00

Market Cap

69.87M

Beta: 0.87

Volume Today

70.65K

Avg: 10.77K

PE Ratio

−8.40

PFCF: −16.74

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides personal...Show More

    Earnings

    Earnings per Share (Estimate*)

    -0.2-0.15-0.1-0.050.052019-04-292020-09-142022-03-152023-07-242024-10-18

    Revenue (Estimate*)

    -10M10M20M30M2019-04-292020-09-142022-03-152023-07-242024-10-18

    *Estimate based on analyst consensus